KRAS and non-small cell lung carcinoma: Germ-free and antibiotic-treated mice were resistant to adenocarcinoma in a KRAS-p53 mouse model of NSCLC and the presence of microbiota in the lung was associated with MyD88 activation in myeloid cells.